Established 1999
 
8,000 companies from
USA,Canada and India.		  
   
Search over 25,000 News & Earnings Archives    
 

DOV Pharmaceutical, Inc.(DOVP)

 
123Jump Rating: - Avoid   Underwriters: Lehman Brothers
      CIBC World Markets
Status: Priced   Lazard Freres & Co. LLC
 
Address: Continental Plaza, 433
 FiledDate: 01/28/2002
  Hackensack Ave.
    
  NJ 07601
 Filed Price Range ($): $15.00-17.00
       
Telephone: 201-968-0980 Filed Offer Amount ($ Million): $65.00
       
Fax: 201-968-0986 Shares Offered (Millions): 5
       
Websites: www.dovpharm.com Shares Outstanding (Millions):
       
Management: Arnold Lippa, Chair.
 IPO Date: 04/24/2002
  Barbara Duncan, Pres./Dir./CEO
    
  Scott Myers, SVP
 Final Offer Price ($): $13.00
       
Industry: Biotech Final Offer Size (Millions of Shares): 0.00
       
Employees: 111 Final Offer Amount ($ Million): $0.00
       
Competitors: Boehringer Ingelheim Pharmaceuticals
 S-1 Forms:
  Sanofi-Aventis
    
  Sepracor
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1997 452 526 -74 0.00 -75 -.03
1998 83 791 -708 0.00 -707 -.27
1999 0.00 2741.511 -2741.511 0.00 -11977.75 -4.02
2000 0.00 3987.48 -3987.48 0.00 -5934.409 -1.99
2001 5711.466 8979 -3267.6 0.00 -5640.455 -1.9
 
 
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
© 1999-2008 123jump.com. All rights reserved